Who will lead the Life Science unit at Merck KGaA?

Jean-Charles Wirth will become the CEO of the Life Science unit, succeeding Matthias Heinzel.

What changes are happening in Merck KGaA's pharmaceuticals division?

Danny Bar-Zohar will take over as CEO of the pharmaceuticals division, succeeding Peter Guenter, who is retiring.

What new role is being created at Merck KGaA?

Khadija Ben Hammada will assume the newly created role of Chief People Officer on March 1.

What responsibilities will Khadija Ben Hammada have?

She will take on additional responsibilities in sustainability, compliance, and site management of the headquarters.

When will the new leadership take effect?

The new leadership for the lab equipment and pharmaceuticals divisions will be effective from June.

Editorial & Advertiser disclosure

Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website.

Home > Headlines > Merck KGaA to replace two executives with company veterans

Headlines

Merck KGaA to replace two executives with company veterans

Published by Global Banking & Finance Review®

Posted on February 18, 2025

1 min read

Last updated: January 26, 2026

Executives of Merck KGaA appointed for leadership roles in pharmaceuticals and life sciences - Global Banking & Finance Review — The image illustrates the new leadership appointments at Merck KGaA, highlighting Jean-Charles Wirth and Danny Bar-Zohar as they assume roles in the company's pharmaceuticals and life sciences divisions, reflecting strategic changes in the banking and finance sector.

Merck KGaA to replace two executives with company veterans

Quick Summary

Merck KGaA Appoints New Leaders for Lab and Pharmaceuticals Divisions

Key Takeaways

Frequently Asked Questions about Merck KGaA to replace two executives with company veterans